YTEN - Yield10 Bioscience GAAP EPS of -$0.71 misses by $0.05 revenue of $0.1M misses by $0.03M
- Yield10 Bioscience press release ( NASDAQ: YTEN ): Q3 GAAP EPS of -$0.71 misses by $0.05 .
- Revenue of $0.1M (+11.1% Y/Y) misses by $0.03M .
- The company continues to estimate total net cash usage for the full year ended December 31, 2022 in a range of $12.0 - $12.5M.
- Yield10's present capital resources are expected to fund its planned operations into Q1 2023.
For further details see:
Yield10 Bioscience GAAP EPS of -$0.71 misses by $0.05, revenue of $0.1M misses by $0.03M